UK markets closed

Qualigen Therapeutics, Inc. (7R9.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.1190-0.0090 (-7.03%)
At close: 08:12AM CEST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/03/2020
Assets
Current assets
Cash
Cash and cash equivalents
401.803
3,166
17,538
153.121
Total cash
401.803
3,166
17,538
153.121
Net receivables
-
538.587
822.351
707.302
Inventory
-
1,586
1,056
660.138
Other current assets
-
12.626
3.577
98.385
Total current assets
1,167
10,821
20,796
1,619
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
-
6,466
6,391
4,920
Accumulated depreciation
-
-4,698
-4,541
-3,408
Net property, plant and equipment
0
26.242
1,850
1,512
Goodwill
-
625.602
0
-
Intangible assets
-
5,846
171.19
-
Other long-term assets
450
8,237
18.334
18.279
Total non-current assets
866.481
8,263
2,039
2,101
Total assets
2,033
19,083
22,836
3,720
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
1,299
60.197
-
1,913
Accounts payable
2,223
619.568
886.224
879.264
Taxes payable
-
4.663
3.62
8.1
Accrued liabilities
430.507
794.559
1,759
1,111
Deferred revenues
-
116.161
135.063
376.622
Other current liabilities
54.6
7,064
1,686
-
Total current liabilities
4,137
8,608
4,635
5,339
Non-current liabilities
Long-term debt
-
-
-
305.805
Deferred tax liabilities
-
357.757
0
-
Deferred revenues
-
49.056
92.928
2.689
Total non-current liabilities
0
1,709
1,635
308.494
Total liabilities
4,137
10,317
6,271
5,648
Stockholders' equity
Common stock
43.262
42.11
35.29
211.757
Retained earnings
-116,802
-103,385
-84,745
-47,301
Accumulated other comprehensive income
0
50.721
0
-
Total stockholders' equity
-2,104
7,236
16,565
-1,928
Total liabilities and stockholders' equity
2,033
19,083
22,836
3,720